Summary.-The mechanisms of non-specific resistance to syngeneic methylcholanthrene-induced fibrosarcomas of mice were investigated. Results showed that a small tumour graft of 0*05 x 105 cells is greatly enhanced in growth when admixed with large numbers of cell fragments, killed cells or viable non-replicating cells. The enhancement of small tumour grafts in cell mixtures was found to be non-specific.
THE BEHAVIOUR and fate of small numbers of tumour cells have been a matter of considerable interest and speculation. Some tumours are capable of immediate growth by experimental inoculation or transplantation of a single cell (Furth & Kahn, 1937) . Others fail to grow under similar circumstances and require relatively more cells before a tumour "take" occurs. Fisher & Fisher (1963) showed that an inoculum of a transplantable tumour, insufficient in numbers to produce growth, can start multiplication weeks later if some stimulus such as laparotomy, or an injection of tissue homogenate at the same implantation site is given. Reve'sz (1958) found that in genetically compatible tumour-host systems, cells irreversibly damaged by heavy doses of radiation exert a profound enhancing influence on the growth of admixed viable cells. In subsequent experiments, Revesz (1 958) showed that the growth stimulation by irradiated cells of small numbers of viable cells failed to occur if the 2 populations were separated.
Recently, the concept of non-specific immune surveillance has been suggested as an important mechanism in the control of tumours (Alexander, 1976) .
The following investigation was undertaken to determine whether carrageenan, a product of marine algae selectively cytotoxic for macrophages (Allison et al., 1966; Schwartz & Leskowitz, 1969; Catanzaro et al., 1971) , would cause the establishment of small numbers of viable tumour cells which would not normally grow. Carrageenan is known to impair delayed hypersensitivity reactions in vivo (Bice et al., 1971; Schwartz & Leskowitz, 1969) and is a potent immunosuppressant of antibody formation (Aschheim & Raffel, 1972; Thomson et al., 1976) . Keller (1976) and Thomson & Fowler (1977) have shown that carrageenan has an enhancing effect on the growth of relatively large tumour-cell inocula. Benjamini et al. (1977) reported that mitomycin C treatment of syngeneic tumour cells prevented replication of such cells, which could still be used to induce specific cell-mediated immunity. The following study involved mitomycin C-treated syngeneic fibrosarcoma cells as a source of non-replicating cells, to see whether they would cause the establishment of small numbers of tumour cells in mixtures and, if so, to determine whether such growth was enhanced by carrageenan.
MATERIALS AND METHODS
Animals.-Male mice (8-10 weeks old) of the highly inbred CBA/H/WEHI strain were used. Their origin and maintenance have been discussed previously (Basten et at., 1974) .
Tumours.-Two syngeneic methylcholanthrene-induced fibrosarcomas designated H-I and H-2 were used. Tumour-cell suspensions were prepared from solid tumours by pronase treatment (Kearney & Nelson, 1973) . Viable tumour cells or mixtures in a total volume of 0-2 ml Dulbecco-modified Eagle's medium (DME), were injected s.c. along the midline of the abdominal wall. Tumour growth was expressed as the average tumour diameter (in units of 0-1 mm) by measuring, at daily intervals after the 4th day, the smallest and largest diameters with a Schnelltaster dial gauge as described previously (Kearney & Nelson, 1973) , or by vernier calipers. The values given in the text are corrected for the average thickness of the uninjected-mouse skin-fold of the abdominal wall.
Preparation of mitomycin C-treated tumour cells (MCT).-Tumour cells obtained by incubation with 0.10% pronase in DME medium were washed x3 in DME medium with 20% foetal calf serum (FCS). Mitomycin C (MC; Kyowa Hakko Kogyo Co. Ltd, Japan) was dissolved in DME medium with 20% FCS and then added to the tumour cells at a concentration of 30 jug/106 H-I tumour cells/ml medium. The cells were incubated at 37°C for 35 min and washed x 3 in mediurn alone to remove free MC and FCS.
Preparation of other inactivated cells.-A single-cell suspension of untreated tumour cells was prepared as described, and suspended to a concentration of 2 x 106 cells in 0-2 ml of DME medium alone.
For heat treatment, this suspension was incubated at 56°C for 35 min. This treatment destroyed the viability of the tumour cells, as indicated by the trypan-blue exclusion test.
For freeze-thawing, the suspension was immersed in liquid N2 and thawed under running tapwater. The procedure was repeated x 3. Viability of the cells was totally destroyed as assessed by trypan-blue exclu- tumour eells per 0-2 ml. For this purpose, it was calculated that latex particles were 1 the diameter of the average tumour cell and that therefore an equivalent volume to 2 x 106 cells would be provided by 2 x 108 latex particles. These mixtures in a volume of 0-2 ml were immediately injected s.c. into the midline of the abdominal wall of normal mice. Therefore, each animal received 0 05 x 105 live H-1 cells mixed with an equivalent of 106 inactivated cells, or 108 latex particles.
Carrageenan.-Lambda carrageenan (Marine Colloids Inc., Springfield, New Jersey) was dissolved in boiling physiological saline at a concentration of 0 5 mg/0-2 ml, and then stored at -20°C until required. The method of carrageenan pretreatment was as follows: animals were given 0 5 mg of carrageenan, injected i.p., on each of 3 days before the test procedure, i.e., before the inoculation of viable cells or admixtures; on the day of the experiment, a final dose of 0-5 mg was administered, about 1 h before the tumour-cell inoculation: thus a total of 2 mg was administered in 4 divided doses.
, (.42 Admixture of 0 05 x 105 H-1 cells with 106 MC-treated tumour cells Fig. 1 and Tables I, II and III show that, whereas a graft of 0 05 x 105 H-1 cells alone produces a tumour in a small minority of normal mice, the same number of cells, mixed with 106 viable nonreplicating MCT cells, will produce a tumour in all normal animals. The resultant tumours grow at a rate comparable to a dose of 0-5 x 105-H-1 cells given alone (Fig. 1) . The enhancement of a low dose of H-I tumour cells is also seen when these cells are admixed with 106 MCtreated H-2 tumour cells. As seen in Fig. 1 Fig. 2 .
Although carrageenan pretreatment sig- (Fig. 3) .
However, if latex particles are mixed with such a graft, tumour growth is totally prevented. This also occurred with a large, optimal dose of tumour cells, so that it is probable that the latex particles were toxic for the cells. A violent inflammatory reaction was seen to occur at the site of injection of latex particles, followed by considerable local ulceration. These experiments demonstrate that a small tumour graft is greatly enhanced in growth when mixed with large numbers of inactivated tumour cells. The same effect results whether or not cells of the same antigenicity are used (H-1 and H-2 tumours do not cross-react antigenically; Wu & Kearney, submitted for publication) and is not dependent on the viability of the added cells. However, the 2 cell populations must be mixed, as a simultaneous injection of inactivated cells and a small graft at 2 different sites does not produce the effect.
Using lethally irradiated cells, Revesz (1958) observed the same effect. His results were confirmed and extended by Toda et al. (1967) , Yatvin et al. (1970) and Hewitt et al. (1973) . The explanation which best fits existing data is that the admixed tumour cells interfere with a local, non-specific clearance mechanism which can normally remove small numbers of injected cells.
The existence of a macrophage-mediated tumour-inhibitory mechanism was indicated by the enhancement of tumour growth by the administration of carrageenan. This observation has been previously reported for both chemically induced (Keller, 1976; Nelson & Nelson, 1978) and virally induced (Lotzova & Richie, 1977) tumours. It is unlikely that the enhancement is due to a direct stimulatory effect of carrageenan on tumour growth, since carrageenan has been shown to be toxic for tumour cells in vitro (Pollack & Nelson, 1973) , although products from damaged macrophages may have an enhancing effect (Keller, 1976) . Carrageenan has many biological effects (Di Rosa, 1972) including anticoagulant activity (Anderson & Duncan, 1965) and inhibition of complement (Borsos et al., 1965) , all of which may affect tumour growth. However, the most likely explanation for the enhancement is that it is due to inhibition of macrophage ftunction. Further evidence for this belief is found in the report of Keller (1976) , who showed that poly-vinyl-pyridine-N-oxide (PVNO) could prevent the enhancement of tumour growth by both carrageenan and silica. PVNO selectively reverses the toxic effects of these agents on macrophages.
If carrageenan is enhancing tumour growth in normal animals by crippling macrophage function, 2 possible mechanisms should be considered:
Firstly, it is conceivable that carrageenan may have prevented the development of specific immunity which normally restrains tumour growth. This is unlikely, since tumour growth has already begun before specific immunity Nwould be expected to have an effect. Also, in view of the lack of effect of carrageenan on the induction and expression of specific immunity by MCT cells (Wu & Kearney, submitted for publication), it is unlikelv that such a mechanism is responsible for the observed enhancement.
A second, more plausible, explanation is that carrageenan pretreatment interferes with a non-specific, macrophagemediated, tumour-inhibitory system which is important in clearing small numbers of tumour cells in animals without specific immunity. This mechanism may mediate a primitive surveillance system which can recognize and dispose of small numbers of neoplasite cells, thus preventing the development of small grafts but only able to reduce the growth potential of larger grafts.
In the context of the present experiments, it could be postulated that admixed inactivated tumour cells could protect small numbers of live cells by providing macrophages with an overwhelming load to handle. Thus the potent cells could escape destruction, while the macrophages were preoccupied with removing harmless, inactivated or dead cells. The observation that carrageenan neither increased nor decreased the effect may be an indication that both carrageenan and admixed cells interfere with the same tumour-inhibitory mechanism and therefore cannot produce additive effects.
In summary these findings, together with the observation that carrageenan greatly enhances tumour growth, lend some support to the concept that a nonspecific, macrophage-mediated "surveillance" system may be as important as specific immunity in determining the growth of syngeneic tumours. 
